Project support to the management of WHO's Global Accelerator for Pediatric Formulations (GAP-f) network, which is focused on accelerating access to safe, effective, quality, affordable pediatric medicines
Project support to test and treat approximately 11,000 people suffering from visceral leishmaniasis per year